Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Huaier Granule in Treating Women With Triple Negative Breast Cancer

NCT02615457 is registered in ClinicalTrials.gov with Shandong University as lead sponsor.

NCT NCT02615457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02615457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Huaier Granule in Treating Women With Triple Negative Breast Cancer
Lead sponsor
Shandong University
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2015
Completion date
Not reported
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

triple negative breast cancer